The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Mirum Pharmaceuticals Inc’s stock clocked out at $48.44, down -0.33% from its previous closing price of $48.60. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 0.71 million shares were traded. MIRM stock price reached its highest trading level at $49.11 during the session, while it also had its lowest trading level at $48.02.
Ratios:
To gain a deeper understanding of MIRM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.15 and its Current Ratio is at 3.34. In the meantime, Its Debt-to-Equity ratio is 1.37 whereas as Long-Term Debt/Eq ratio is at 1.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on April 17, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On December 18, 2023, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $60 to $58.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 24 ’25 when Radovich Peter sold 3,177 shares for $47.92 per share. The transaction valued at 152,256 led to the insider holds 29,588 shares of the business.
Howe Jolanda sold 902 shares of MIRM for $43,228 on Jan 24 ’25. The SVP, GLOBAL CONTROLLER now owns 3,524 shares after completing the transaction at $47.92 per share. On Jan 24 ’25, another insider, Peetz Christopher, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 6,837 shares for $47.92 each. As a result, the insider received 327,658 and left with 125,022 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 2325342720 and an Enterprise Value of 2358548992. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.57 while its Price-to-Book (P/B) ratio in mrq is 10.01. Its current Enterprise Value per Revenue stands at 7.682 whereas that against EBITDA is -32.352.
Stock Price History:
The Beta on a monthly basis for MIRM is 0.96, which has changed by 0.83257914 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, MIRM has reached a high of $49.58, while it has fallen to a 52-week low of $23.14. The 50-Day Moving Average of the stock is 9.73%, while the 200-Day Moving Average is calculated to be 29.50%.
Shares Statistics:
It appears that MIRM traded 432.02K shares on average per day over the past three months and 539240 shares per day over the past ten days. A total of 47.97M shares are outstanding, with a floating share count of 38.31M. Insiders hold about 20.19% of the company’s shares, while institutions hold 94.39% stake in the company. Shares short for MIRM as of 1736899200 were 6649342 with a Short Ratio of 15.39, compared to 1734048000 on 6843628. Therefore, it implies a Short% of Shares Outstanding of 6649342 and a Short% of Float of 16.08.
